← Eichor
Condition: Parainfluenza Virus Piv Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Parainfluenza Virus Piv

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Phase 3 · 28 location(s) · Ansun Biopharma, Inc. · NCT03808922PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Viru
Phase 2 · 11 location(s) · Pulmotect, Inc. · NCT06665100Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04099082
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.